Integrated Riskfree Intensivecare Services Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 23-12-2024
- Paid Up Capital ₹ 0.20 M
as on 23-12-2024
- Company Age 8 Year, 17 Days
- Last Filing with ROC 31 Mar 2024
- Revenue -4.47%
(FY 2022)
- Profit -75.64%
(FY 2022)
- Ebitda -67.06%
(FY 2022)
- Net Worth 10.00%
(FY 2022)
- Total Assets 4.70%
(FY 2022)
About Integrated Riskfree Intensivecare Services
The Company is engaged in the Internet Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Latchamsetty Sanjay, Krishna Kasam, Praveen Koppula, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999TG2017PTC113917
- Company No.
113917
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jan 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Integrated Riskfree Intensivecare Services?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Praveen Koppula  | Director | 06-Jan-2017 | Current |
| Latchamsetty Sanjay | Director | 06-Jan-2017 | Current |
| Krishna Kasam | Director | 06-Jan-2017 | Current |
| Armugam Ponnuswamy | Director | 06-Jan-2017 | Current |
Financial Performance of Integrated Riskfree Intensivecare Services.
Integrated Riskfree Intensivecare Services Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 4.47% decrease. The company also saw a substantial fall in profitability, with a 75.64% decrease in profit. The company's net worth by .
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Integrated Riskfree Intensivecare Services?
Unlock access to Integrated Riskfree Intensivecare Services's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Integrated Riskfree Intensivecare Services?
Unlock and access historical data on people associated with Integrated Riskfree Intensivecare Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Integrated Riskfree Intensivecare Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Integrated Riskfree Intensivecare Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.